Reference
The state programme has been developed in pursuance of Presidential Executive Order No. 596 of 7 May 2012, On Long-Term State Economic Policy.
The state programme seeks to improve public health and enhance the performance of healthcare institutions by regularly upgrading the industry’s technological base, developing medical science and education, improving human resources, implementing IT solutions and introducing up-to-date management standards.
The Ministry of Healthcare is the principal executor of the state programme, the Federal Medical-Biological Agency has been designated as its co-executor, and the state programme’s participants are the Ministry of Labour and Social Protection, the Ministry of Industry and Trade, the Ministry of Energy, the Ministry of Defence, the Ministry of Agriculture, the Ministry of Economic Development, the Ministry of Finance, the Ministry of Foreign Affairs, the Federal Service for Supervision of Healthcare and Social Development, the Federal Agency for Air Transport, the Federal Road Agency, the Federal Agency for Sea and Inland Water Transport, the Federal Service for Supervision of Consumer Protection and Welfare, the Federal Agency for State Property Management, the Federal Taxation Service, the Federal Bailiff Service, the Russian Academy of Sciences, the Siberian Division of the Russian Academy of Sciences, the Ural Division of the Russian Academy of Sciences, the Far Eastern Division of the Russian Academy of Sciences, the Russian Academy of Medical Sciences and the Mandatory Medical Insurance Fund.
The state programme comprises the following sub-programmes:
- Sub-programme 1: Preventing disease, encouraging healthy lifestyles, and developing primary healthcare;
- Sub-programme 2: Improving specialised medical care and high-tech care, emergency care and specialised emergency care, and medical evacuation;
- Sub-programme 3: Developing and introducing innovative disease detection, prevention and treatment methods, and the basics of personalised medicine;
- Sub-programme 4: Healthcare for mothers and children;
- Sub-programme 5: Developing medical rehabilitation and health resort treatment, including for children;
- Sub-programme 6: Providing palliative care, including for children;
- Sub-programme 7: Staffing the healthcare system;
- Sub-programme 8: Facilitating international cooperation on healthcare issues;
- Sub-programme 9: Expert examination, monitoring and oversight in the healthcare segment;
- Sub-programme 10: Health service support for specific population categories;
- Sub-programme 11: Managing programme implementation.
The state programme aims to make medical care more accessible and more efficient, with the volume, quality and types of care commensurate to disease incidence rates and the needs of the population, and consistent with the latest medical advances.
Objectives of the programme:
- prioritising prevention and primary medical care in healthcare;
- enhancing the effectiveness of emergency care and specialised medical care, including high-tech treatments;
- developing and introducing innovative disease detection, prevention and treatment methods, as well as personalised medical technologies;
- making obstetrics and child welfare services more effective;
- expanding medical rehabilitation and health resort treatment;
- palliative care for patients suffering from incurable diseases;
- staffing the healthcare system with highly qualified and motivated personnel;
- greater transparency and effectiveness of healthcare supervision and oversight;
- ensuring consistent, comprehensive development throughout the industry.
Initiatives to foster innovation in the healthcare industry are outlined in Sub-programme 3, Developing and Introducing Innovative Disease Detection, Prevention and Treatment Methods, and the Basics of Personalised Medicine. The main initiatives of Sub-programme 3 mirror the provisions of the Strategy for Russia’s Innovative Development to 2020:
- fostering innovation in the healthcare industry with the aim of producing concrete innovative solutions and introducing them in practice in cooperation with government development institutions;
- planning and coordinating efforts in priority research areas at new technology platforms and under the pilot projects of innovative territorial clusters;
- removing administrative barriers to innovation;
- coordinating the innovative activities of R&D institutions of the Ministry of Healthcare, the Russian Academy of Sciences and the Russian Academy of Medical Sciences;
- increasing the number of young people who go into medicine.
The state programme covers the development of Russia’s healthcare system to 2020 and is divided into two stages:
- first stage (2013-2015): structural reforms;
- second stage (2016-2020): developing the healthcare system’s innovative capabilities.
Federal funding for the state programme has been set at the level necessary to achieve the indicators outlined in Presidential Executive Orders No. 597, 598 and 606 of 7 May 2012, in the Concept for Long-Term Socioeconomic Development to 2020 and the Concept for Russia’s Demographic Policy to 2025.
Funding for the state programme at all budget levels totals 33.721 trillion roubles, including 6.0675 trillion roubles from the federal budget – 2.7106 trillion roubles from existing budget commitments and 3.3569 trillion roubles in additional funding.
Funding levels for the programme shall be detailed in federal budget drafts for the relevant year and planning period.
Main outcomes of the state programme:
- fostering lasting motivation in the population to lead healthy lifestyles;
- greater satisfaction with the quality of medical services;
- ensuring that every Russian citizen regardless of place of residence can take advantage of guaranteed healthcare services that meet uniform standards in terms of accessibility and quality;
- forming research and education clusters at the country’s best medical schools;
- outlining uniform state priorities for biomedicine and the creation of new scientific schools;
- raising the prestige of medical professions and improving the qualifications of professionals by substantially increasing salaries, among other things;
- creating conditions for population growth and higher life expectancy.
The programme’s success will be judged by the following criteria:
- by 2020, reducing the total mortality rate to 11.4 per 1,000 people;
- by 2020, reducing deaths in childbirth to 15.5 per 100,000 live births and infant mortality to 6.4 per 1,000 live births;
- by 2020, reducing the mortality rate (per 100,000 people) from circulatory system diseases to 622.4, from road traffic accidents to 10, from tumours and cancer to 190, and from tuberculosis to 11.2;
- by 2020, reducing annual consumption of alcohol to the equivalent of 10 litres of absolute alcohol per person, and reducing tobacco use to 25% among adults and 15% among teenagers;
- by 2020, reducing tuberculosis incidence to 35 cases per 100,000 people;
- by 2020, ensuring a doctor density of 44.8 per 10,000 people, and reaching a ratio of one doctor per three nurses;
- by 2018, increasing the average salary of doctors and medical professionals with an advanced medical or pharmaceutical degree or a degree in fields related to medical services (or supporting the provision of medical services) to 200% of the average salary in each region, and increasing the salary of mid-level medical (pharmaceutical) professionals and junior medical professionals (or those supporting the provision of medical services) to match the average salary in each region;
- by 2020, increasing life expectancy at birth to 74.3 years.